organization · Reporting owner
South Cone Investments Limited Partnership
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FTC Solar, Inc.FTCI · Entity 7353 | 10% owner | December 13, 2022 | December 15, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FTC Solar, Inc.
Report date December 13, 2022 · Filed December 15, 2022
Jointly reported with South Lake One LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectShares indirectly held through South Lake One LLC | 14,867,592 |
Last balance in matching sequence
After 2022-12-14 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2022-12-13 · Purchase · Acquired 36,230 · Balance 14,861,860 F1: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.76 per share, inclusive. The reporting persons undertake to provide FTC Solar, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Row 2 · 2022-12-14 · Purchase · Acquired 5,732 · Balance 14,867,592 F2: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.765 to $2.80 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.76 per share, inclusive. The reporting persons undertake to provide FTC Solar, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.765 to $2.80 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
F3: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Rani Therapeutics Holdings, Inc.
Report date October 20, 2025 · Filed October 22, 2025
Section 16 reporting ended · disclosed 2025-10-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectShares indirectly held through South Lake One LLC | 2,379,194 |
Last balance in matching sequence
After 2025-10-21 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-10-20 · Sale · Disposed 1,923,000 · Balance 6,379,194 F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.25 to $2.61, inclusive. The reporting person undertakes to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Row 2 · 2025-10-21 · Sale · Disposed 4,000,000 · Balance 2,379,194 F3: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $3.09, inclusive. The reporting person undertakes to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.25 to $2.61, inclusive. The reporting person undertakes to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.
F3: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $3.09, inclusive. The reporting person undertakes to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2025 Filed Oct 22, 2025 22:57 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | SaleClass A Common Stock | 4,000,000 | $2.77 | $11,074,000.00 |
DisclosureSEC source: 0001104659-25-101613 · tm2529290-2_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 2,379,194 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $3.09, inclusive. The reporting person undertakes to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 22:57 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | SaleClass A Common Stock | 1,923,000 | $2.41 | $4,637,314.50 |
DisclosureSEC source: 0001104659-25-101613 · tm2529290-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,379,194 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.25 to $2.61, inclusive. The reporting person undertakes to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:30 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | SaleClass A Common Stock | 523,738 | $3.26 | $1,705,395.68 |
DisclosureSEC source: 0001104659-24-109543 · tm2426414-2_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 8,302,194 F3 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 16:30 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | SaleClass A Common Stock | 3,305,622 | $2.55 | $8,436,277.91 |
DisclosureSEC source: 0001104659-24-109543 · tm2426414-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 8,825,932 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| November 24, 2023 Filed Dec 8, 2023 16:27 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 5,265,165 | $2.01 | $10,582,981.65 |
DisclosureSEC source: 0001104659-23-124719 · tm2332512-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 12,131,554 F1 · kind: The Reporting Person acquired 5,265,165 shares of the Issuer's Class A Common Stock in a private secondary offering that was priced at the prevailing market price. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| May 12, 2023 Filed May 15, 2023 16:22 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 2,645 | $3.98 | $10,529.48 |
DisclosureSEC source: 0001104659-23-060817 · tm2314845-3_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,866,389 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.89 to $4.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| May 11, 2023 Filed May 15, 2023 16:22 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 2,610 | $3.87 | $10,096.26 |
DisclosureSEC source: 0001104659-23-060817 · tm2314845-3_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,863,744 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.78 to $3.99 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:25 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 4,420 | $4.46 | $19,733.09 |
DisclosureSEC source: 0001104659-23-058462 · tm2314845-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,861,134 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.26 to $4.62 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| May 03, 2023 Filed May 5, 2023 13:26 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 2,040 | $4.81 | $9,816.07 |
DisclosureSEC source: 0001104659-23-056424 · tm2314845-1_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,856,714 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.83 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 28, 2023 Filed May 2, 2023 13:09 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 2,173 | $4.71 | $10,225.05 |
DisclosureSEC source: 0001104659-23-054940 · tm2311848-9_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,854,674 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.645 to $4.80 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 17:09 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 4,423 | $4.51 | $19,952.15 |
DisclosureSEC source: 0001104659-23-050432 · tm2311848-8_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,852,501 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.39 to $4.60 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 17:09 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 4,280 | $4.67 | $19,994.45 |
DisclosureSEC source: 0001104659-23-050432 · tm2311848-8_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,848,078 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.66 to $4.705 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 17:25 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 4,100 | $4.93 | $20,223.66 |
DisclosureSEC source: 0001104659-23-049097 · tm2311848-7_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,843,798 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $5.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 20, 2023 Filed Apr 24, 2023 17:25 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,850 | $5.32 | $9,850.51 |
DisclosureSEC source: 0001104659-23-049097 · tm2311848-7_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,839,698 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.32 to $5.38 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 15:23 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,850 | $5.37 | $9,938.94 |
DisclosureSEC source: 0001104659-23-047682 · tm2311848-6_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,837,848 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.37 to $5.40 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 13:50 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,901 | $5.27 | $10,019.03 |
DisclosureSEC source: 0001104659-23-046614 · tm2311848-5_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,835,998 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.20 to $5.29 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 13, 2023 Filed Apr 14, 2023 16:21 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 890 | $5.47 | $4,863.85 |
DisclosureSEC source: 0001104659-23-045603 · tm2312872-1_4seq.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,834,097 F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 16:21 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,577 | $5.48 | $19,585.15 |
DisclosureSEC source: 0001104659-23-045603 · tm2312872-1_4seq.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,833,207 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.405 to $5.59 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 11, 2023 Filed Apr 12, 2023 12:22 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,765 | $5.58 | $9,845.88 |
DisclosureSEC source: 0001104659-23-044438 · tm2311848-4_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,829,630 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.57 to $5.66 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 12:22 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,923 | $5.07 | $9,744.23 |
DisclosureSEC source: 0001104659-23-044438 · tm2311848-4_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,827,865 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 13:54 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 7,551 | $5.14 | $38,775.14 |
DisclosureSEC source: 0001104659-23-043508 · tm2311848-3_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,825,942 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.12 to $5.24 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 13:16 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 7,280 | $5.49 | $39,945.36 |
DisclosureSEC source: 0001104659-23-042563 · tm2311848-2_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,818,391 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.42 to $5.50 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 13:16 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 4,416 | $5.49 | $24,246.49 |
DisclosureSEC source: 0001104659-23-042563 · tm2311848-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,811,111 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.43 to $5.50 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 11:48 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,587 | $5.23 | $18,748.53 |
DisclosureSEC source: 0001104659-23-041984 · tm2311848-1_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,806,695 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.12 to $5.35 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 14:16 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 751 | $5.05 | $3,790.75 |
DisclosureSEC source: 0001104659-23-040729 · tm238347d10_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,803,108 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.95 to $5.12 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 14:16 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 12,230 | $4.79 | $58,582.92 |
DisclosureSEC source: 0001104659-23-040729 · tm238347d10_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,802,357 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $5.58 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 14:51 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,510 | $5.49 | $19,282.89 |
DisclosureSEC source: 0001104659-23-039082 · tm238347-9_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,790,127 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.40 to $5.605 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 21, 2023 Filed Mar 22, 2023 12:48 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,230 | $6.08 | $19,637.11 |
DisclosureSEC source: 0001104659-23-035492 · tm238347-8_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,786,617 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.00 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 12:48 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 532 | $6.29 | $3,347.66 |
DisclosureSEC source: 0001104659-23-035492 · tm238347-8_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,783,387 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.27 to $6.30 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 17, 2023 Filed Mar 20, 2023 12:13 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 2,980 | $6.19 | $18,447.99 |
DisclosureSEC source: 0001104659-23-034345 · tm238347-7_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,782,855 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.10 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 12:13 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,325 | $6.07 | $8,045.40 |
DisclosureSEC source: 0001104659-23-034345 · tm238347-7_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,779,875 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.02 to $6.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 11:15 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 2,463 | $6.14 | $15,120.60 |
DisclosureSEC source: 0001104659-23-032652 · tm238347-6_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,778,550 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.06 to $6.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 14:48 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,730 | $6.56 | $24,487.08 |
DisclosureSEC source: 0001104659-23-031099 · tm238347-4_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,776,087 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.45 to $6.67 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 14:48 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,702 | $6.58 | $11,202.22 |
DisclosureSEC source: 0001104659-23-031099 · tm238347-4_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,772,357 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.505 to $6.60 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 10:10 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,100 | $6.39 | $7,031.97 |
DisclosureSEC source: 0001104659-23-029919 · tm238347-3_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,770,655 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.36 to $6.40 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 15:26 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,900 | $6.31 | $24,609.00 |
DisclosureSEC source: 0001104659-23-028960 · tm238347-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,769,555 F1 · price: These shares were purchased in a single transaction at a price of $6.31 per share. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 12:14 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 711 | $6.30 | $4,478.30 |
DisclosureSEC source: 0001104659-23-027777 · tm238347-1_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,765,655 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.29 to $6.30 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 11:24 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,541 | $6.30 | $22,308.30 |
DisclosureSEC source: 0001104659-23-026516 · tm237665-2_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,764,944 F2 · price: These shares were purchased in multiple transactions, each at $6.30 per share. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 11:24 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 5,451 | $6.09 | $33,179.69 |
DisclosureSEC source: 0001104659-23-026516 · tm237665-2_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,761,403 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.01 to $6.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 15:17 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 1,000 | $6.10 | $6,100.00 |
DisclosureSEC source: 0001104659-23-024727 · tm237665-1_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,755,952 F2 · price: These shares were purchased in multiple transactions, each at $6.10 per share. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 15:17 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 3,080 | $5.94 | $18,299.82 |
DisclosureSEC source: 0001104659-23-024727 · tm237665-1_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,754,952 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.85 to $6.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 10:37 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 8,468 | $5.88 | $49,791.84 |
DisclosureSEC source: 0001104659-23-023608 · tm237324-1_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,751,872 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.72 to $6.00 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 10:37 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 9,500 | $5.49 | $52,125.55 |
DisclosureSEC source: 0001104659-23-023608 · tm237324-1_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,743,404 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.21 to $5.62 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 12:50 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 10,000 | $5.20 | $52,049.00 |
DisclosureSEC source: 0001104659-23-022702 · tm237124-1_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,733,904 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.08 to $5.25 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 12:50 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 9,250 | $5.25 | $48,563.43 |
DisclosureSEC source: 0001104659-23-022702 · tm237124-1_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,723,904 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.995 to $5.52 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 20:08 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 8,600 | $5.98 | $51,452.08 |
DisclosureSEC source: 0001104659-23-000498 · tm2231865-7_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,714,654 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.80 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 20:08 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 8,600 | $5.97 | $51,309.32 |
DisclosureSEC source: 0001104659-23-000498 · tm2231865-7_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,706,054 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.75 to $6.23 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 15:23 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 9,157 | $5.58 | $51,056.68 |
DisclosureSEC source: 0001104659-22-130920 · tm2231865-6_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,697,454 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.42 to $5.71 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 14:57 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 6,900 | $7.43 | $51,284.25 |
DisclosureSEC source: 0001104659-22-128587 · tm2232650-4_4seq1.xml · nonDerivative · entry 2 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,688,297 F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.60 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 14:57 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | PurchaseClass A Common Stock | 6,400 | $7.76 | $49,688.32 |
DisclosureSEC source: 0001104659-22-128587 · tm2232650-4_4seq1.xml · nonDerivative · entry 1 South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner South Lake One LLC · CIK 0001794292 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares indirectly held through South Lake One LLC Disclosed balance after: 6,681,397 F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.36 to $8.09 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.